Skip to content
BOE-A-2026-10324 ·13 May 2026 ·Royal Decree-Law critical
Labour

Users and beneficiaries of outpatient pharmaceutical benefits: 3 months to adjust contributions or fines of up to 1,500 EUR for non-compliance

The regulation modifies Article 102 of RDL 1/2015 to establish new contribution conditions for users and beneficiaries in outpatient pharmaceutical benefits. A three-month period is set to adjust contributions or fines of up to 1,500 EUR for non-compliance (art. 102). The change aims to improve transparency and compliance in the pharmaceutical benefit financing system.

In 2 key points

  1. Users and beneficiaries must adjust contributions within three months (art. 102)
  2. Failure to comply incurs fines of up to 1,500 EUR (art. 102)

How it affects those involved

Beneficiaries of outpatient pharmaceutical benefits must revise their contributions within three months; failure to do so incurs fines of up to 1,500 EUR per case (art. 102). Health authorities will have enhanced oversight. Pension and social security beneficiaries affected must review their contributions. No impact on the public health system or other sectors.

Lifecycle

2026-05-13PublishedPublished in the BOE
2026-08-13Into forceComes into force (disposicion final primera)
Official text Based on BOE data (boe.es). Information, not advice.

Does this provision affect you?

The labour team reviews your specific situation.

Talk to the labour team
This analysis is informational only and does not constitute legal advice or create a client-adviser relationship. BM Consulting.
Email
Contact